Dataset Information

Differentiation of Heart Failure Patients by the Ratio of the Scaling Exponents of Cardiac Interbeat Intervals.

ABSTRACT: Heart failure (HF) is one of the most frequent heart diseases. It is usually characterized with structural and functional cardiac abnormalities followed by dysfunction of autonomic cardiac control. Current methods of heartbeat interval analysis are not capable to differentiate HF patients and some new differentiation of HF patients could be useful in the determination of the direction of their treatment. In this study, we examined potential of the ratio of the short-term and long-term scaling exponents (? ₁ and ? ₂) to separate HF patients with similar level of reduced cardiac autonomic nervous system control and with no significant difference in age, left ventricular ejection fraction (LVEF) and NYHA class. Thirty-five healthy control subjects and 46 HF patients underwent 20 min of continuous supine resting ECG recording. The interbeat interval time series were analyzed using standardized power spectrum analysis, detrended fluctuation analysis method and standard Poincaré plot (PP) analysis with measures of asymmetry of the PP. Compared with healthy control group, in HF patients linear measures of autonomic cardiac control were statistically significantly reduced (p < 0.05), heart rate asymmetry was preserved (C _up > C _down, p < 0.01), and long-term scaling exponent ? ₂ was significantly higher. Cluster analysis of the ratio of short- and long-term scaling exponents showed capability of this parameter to separate four clusters of HF patients. Clusters were determined by interplay of presence of short-term and long-term correlations in interbeat intervals. Complementary measure, commonly accepted ratio of the PP descriptors, SD2/SD1, showed tendency toward statistical significance to separate HF patients in obtained clusters. Also, heart rate asymmetry was preserved only in two clusters. Finally, a multiple regression analysis showed that the ratio ? ₁/? ₂ could be used as an integrated measure of cardiac dynamic with complex physiological background which, besides spectral components as measures of autonomic cardiac control, also involves breathing frequency and mechanical cardiac parameter, left ventricular ejection fraction.

SUBMITTER: Platisa MM

PROVIDER: S-EPMC6527786 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Differentiation of Heart Failure Patients by the Ratio of the Scaling Exponents of Cardiac Interbeat Intervals.

Platiša Mirjana M MM Radovanović Nikola N NN Kalauzi Aleksandar A Milašinović Goran G Pavlović Siniša U SU

Frontiers in physiology 20190514

Heart failure (HF) is one of the most frequent heart diseases. It is usually characterized with structural and functional cardiac abnormalities followed by dysfunction of autonomic cardiac control. Current methods of heartbeat interval analysis are not capable to differentiate HF patients and some new differentiation of HF patients could be useful in the determination of the direction of their treatment. In this study, we examined potential of the ratio of the short-term and long-term scaling ex ...[more]

PMID: 31139094

Similar Datasets

Project description:AimsThe importance of true worsening renal failure (WRF), which is associated with a poor prognosis, had been suggested in patients with acute heart failure (AHF). The aim of the present study was to establish the biomarker strategy for the prediction of true WRF in AHF.Methods and resultsTwo hundred eighty-one patients with AHF were analysed. Their biomarkers were measured within 30 min of admission. Patients were assigned to the non-WRF (n = 168), pseudo-WRF (n = 56), or true-WRF (n = 57) groups using the criteria of both acute kidney injury on admission and increasing serum creatinine value during the first 7 days. A Kaplan-Meier curve showed that the survival and heart failure event rate of the true-WRF group within 1000 days was significantly lower than that of the non-WRF and pseudo-WRF groups (P ≤ 0.001). The multivariate Cox regression model also indicated that true WRF was an independent predictor of 1000 day mortality and heart failure events [hazard ratio: 4.315, 95% confidence interval (CI): 2.466-7.550, P ≤ 0.001, and hazard ratio: 2.834, 95% CI: 1.893-4.243, P ≤ 0.001, respectively]. The serum heart-type fatty acid-binding protein (s-HFABP) levels were significantly higher in the true-WRF group than in the non-WRF and pseudo-WRF groups (P ≤ 0.001). The multivariate logistic regression model indicated that the predictive biomarker for the true-WRF group was the s-HFABP level (odds ratio: 5.472, 95% CI: 2.729-10.972, P ≤ 0.001). The sensitivity and specificity for indicating the presence of true WRF were 73.7% and 76.8% (area under the curve = 0.831) for s-HFABP in whole patients, respectively, and 94.7% and 72.7% (area under the curve = 0.904) in non-chronic kidney disease (CKD) patients, respectively.ConclusionsCardiac biomarkers, especially the s-HFABP, might predict the development of true WRF in AHF patients. Furthermore, the predictive value was higher in AHF patients without CKD than in those with CKD.

Dataset Information

Differentiation of Heart Failure Patients by the Ratio of the Scaling Exponents of Cardiac Interbeat Intervals.

Publications

Differentiation of Heart Failure Patients by the Ratio of the Scaling Exponents of Cardiac Interbeat Intervals.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets